The sub-three-hour marathon is one of running’s most coveted milestones. It means averaging 6:52 per mile for 26.2 miles, a pace that demands not just fitness but—for many runners—a near-perfect ...

EL PASO, Texas (KVIA) -- The El Paso Independent School District invited families and students at Mesita Elementary School Wednesday at its Connecting Worlds/Mundos Unidos Gifted & Talented Expo and ...

Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical Program Tempus AI, Inc., a leader in ...

A team led by Worcester Polytechnic Institute (WPI) researcher Nitin J. Sanket has shown that ultrasound sensors and a form of artificial intelligence (AI) can enable palm-sized aerial robots to ...

MOREE, NSW, AUSTRALIA, March 26, 2026 /EINPresswire.com/ — Arkisys™, a leader in on-orbit services and space robotics operations, and SpacePort Australia ® (SPA ...

Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced a strategic collaboration with Daiichi Sankyo (TSE: 4568) aimed at accelerating the clinical development ...

If you want to advance your career, you’ll need to build a strong network. The statistics make the case: 54% of people report getting their job through a connection, according to a 2025 survey by ...

Johnny C. Taylor Jr. tackles your workplace questions each week for USA TODAY. Taylor is president and CEO of SHRM, the world's largest trade association of human resources professionals, and author ...

-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s Inflammation Portfolio -- -- Gilead Intends to Enter into a Strategic ...

LAS VEGAS--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced an investment in DaVinci Commerce, a leader in agentic AI-powered commerce—a rapidly emerging channel, where AI systems increasingly shape ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company ...